Skip to main content

Sponsor

This clinical study is sponsored by the Montreal Heart Institute (MHI) and coordinated by the Montreal Health Innovations Coordinating Center (MHICC).

Study instigators

BRAIN-AF was developed by a team of specialized cardiologists at the Montreal Heart Institute.

Dr. Lena Rivard

Cardiologist and electrophysiologist at the Montreal Heart Institute
Associate Professor of Medicine at the University of Montreal and principal investigator of the BRAIN-AF study

Dr.Paul Khairy

Cardiologist and electrophysiologist at the Montreal Heart Institute
Professor of Medicine at the University of Montreal
André Chagnon Research Chair in Congenital Heart Disease

Dr. Denis Roy

Cardiologist and electrophysiologist at the Montreal Heart Institute
Professor of Medicine at the University of Montreal

Financing

This research is made possible thanks to the support of generous donors:

  • Canadian Institute of Health Research (CIHR)
  • Canadian Stroke Prevention Intervention Network (C-SPIN)
  • Hewitt Foundation
  • Bayer Global
  • Godin Family Foundation
  • Saputo Inc.
  • iA Financial Group
  • Foundation of Greater Montréal, Paul-A. Fournier Foundation Fund
  • SoundBite Medical Solutions
  • Libermont Foundation
  • Bryan Jones
  • The Jean C. Monty Family
  • Louis A. Tanguay
  • Serge Archambault
  • Montreal Heart Institute Foundation (MHIF)

Bayer Global Inc provides drugs used in this study.

About the Montreal Heart Institute

Founded in 1954, the Montreal Heart Institute constantly strives for the highest standards of excellence in the cardiovascular field through its leadership in clinical and fundamental research, ultra-specialized care, professional training, and prevention. It is home to Canada’s largest cardiology research centre, cardiovascular prevention centre, and cardiovascular genetics centre. The Institute is affiliated with the Université de Montréal and has more than 2,000 employees, including 245 physicians and more than 85 researchers.

About the Montreal Health Innovations Coordinating Centre (MHICC)

The Montreal Health Innovations Coordinating Center (MHICC) is a leading academic clinical research organization and an integral part of the Montreal Heart Institute (MHI). The MHICC possesses an established network of collaborators in over 4,500 clinical sites in more than 35 countries. It has specific expertise in precision medicine, low-cost high-quality clinical trials, and drug repurposing.